293 related articles for article (PubMed ID: 23345622)
1. A hepcidin lowering agent mobilizes iron for incorporation into red blood cells in an adenine-induced kidney disease model of anemia in rats.
Sun CC; Vaja V; Chen S; Theurl I; Stepanek A; Brown DE; Cappellini MD; Weiss G; Hong CC; Lin HY; Babitt JL
Nephrol Dial Transplant; 2013 Jul; 28(7):1733-43. PubMed ID: 23345622
[TBL] [Abstract][Full Text] [Related]
2. Hepcidin as a predictive factor and therapeutic target in erythropoiesis-stimulating agent treatment for anemia of chronic disease in rats.
Theurl M; Nairz M; Schroll A; Sonnweber T; Asshoff M; Haschka D; Seifert M; Willenbacher W; Wilflingseder D; Posch W; Murphy AT; Witcher DR; Theurl I; Weiss G
Haematologica; 2014 Sep; 99(9):1516-24. PubMed ID: 24895335
[TBL] [Abstract][Full Text] [Related]
3. JTZ-951 (enarodustat), a hypoxia-inducible factor prolyl hydroxylase inhibitor, improves iron utilization and anemia of inflammation: Comparative study against recombinant erythropoietin in rat.
Shinozaki Y; Fukui K; Kobayashi H; Yoshiuchi H; Matsuo A; Matsushita M
Eur J Pharmacol; 2021 May; 898():173990. PubMed ID: 33657422
[TBL] [Abstract][Full Text] [Related]
4. The Hepcidin-Anemia Axis: Pathogenesis of Anemia in Chronic Kidney Disease.
Nakanishi T; Kimura T; Kuragano T
Contrib Nephrol; 2019; 198():124-134. PubMed ID: 30991414
[TBL] [Abstract][Full Text] [Related]
5. Hepcidin: clinical utility as a diagnostic tool and therapeutic target.
Coyne DW
Kidney Int; 2011 Aug; 80(3):240-4. PubMed ID: 21677632
[TBL] [Abstract][Full Text] [Related]
6. Possible mechanisms by which silkworm faeces extract ameliorates adenine-induced renal anaemia in rats.
Mei H; Wu N; Huang X; Cui Z; Xu J; Yang X; Zeng F; Wang K
J Ethnopharmacol; 2021 Feb; 266():113448. PubMed ID: 33022342
[TBL] [Abstract][Full Text] [Related]
7. Iron-hepcidin dysmetabolism, anemia and renal hypoxia, inflammation and fibrosis in the remnant kidney rat model.
Garrido P; Ribeiro S; Fernandes J; Vala H; Bronze-da-Rocha E; Rocha-Pereira P; Belo L; Costa E; Santos-Silva A; Reis F
PLoS One; 2015; 10(4):e0124048. PubMed ID: 25867633
[TBL] [Abstract][Full Text] [Related]
8. Alteration of mRNA expression of molecules related to iron metabolism in adenine-induced renal failure rats: a possible mechanism of iron deficiency in chronic kidney disease patients on treatment.
Hamada Y; Kono TN; Moriguchi Y; Higuchi M; Fukagawa M
Nephrol Dial Transplant; 2008 Jun; 23(6):1886-91. PubMed ID: 18174266
[TBL] [Abstract][Full Text] [Related]
9. Testosterone administration inhibits hepcidin transcription and is associated with increased iron incorporation into red blood cells.
Guo W; Bachman E; Li M; Roy CN; Blusztajn J; Wong S; Chan SY; Serra C; Jasuja R; Travison TG; Muckenthaler MU; Nemeth E; Bhasin S
Aging Cell; 2013 Apr; 12(2):280-91. PubMed ID: 23399021
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of Bmp/Smad signaling by Tmprss6 is required for maintenance of systemic iron homeostasis.
Finberg KE; Whittlesey RL; Fleming MD; Andrews NC
Blood; 2010 May; 115(18):3817-26. PubMed ID: 20200349
[TBL] [Abstract][Full Text] [Related]
11. Characterization of erythropoietin and hepcidin in the regulation of persistent injury-associated anemia.
Alamo IG; Kannan KB; Smith MA; Efron PA; Mohr AM
J Trauma Acute Care Surg; 2016 Oct; 81(4):705-12. PubMed ID: 27398985
[TBL] [Abstract][Full Text] [Related]
12. The bone morphogenetic protein-hepcidin axis as a therapeutic target in inflammatory bowel disease.
Wang L; Trebicka E; Fu Y; Ellenbogen S; Hong CC; Babitt JL; Lin HY; Cherayil BJ
Inflamm Bowel Dis; 2012 Jan; 18(1):112-9. PubMed ID: 21351217
[TBL] [Abstract][Full Text] [Related]
13. Hepcidin in anemia of chronic kidney disease: review for the pediatric nephrologist.
Atkinson MA; White CT
Pediatr Nephrol; 2012 Jan; 27(1):33-40. PubMed ID: 21400189
[TBL] [Abstract][Full Text] [Related]
14. The uremic toxin indoxyl sulfate interferes with iron metabolism by regulating hepcidin in chronic kidney disease.
Hamano H; Ikeda Y; Watanabe H; Horinouchi Y; Izawa-Ishizawa Y; Imanishi M; Zamami Y; Takechi K; Miyamoto L; Ishizawa K; Tsuchiya K; Tamaki T
Nephrol Dial Transplant; 2018 Apr; 33(4):586-597. PubMed ID: 28992067
[TBL] [Abstract][Full Text] [Related]
15. Does hepatic hepcidin play an important role in exercise-associated anemia in rats?
Liu YQ; Chang YZ; Zhao B; Wang HT; Duan XL
Int J Sport Nutr Exerc Metab; 2011 Feb; 21(1):19-26. PubMed ID: 21411831
[TBL] [Abstract][Full Text] [Related]
16. Deregulated iron metabolism in bone marrow from adenine-induced mouse model of chronic kidney disease.
Kimura T; Kuragano T; Yamamoto K; Nanami M; Hasuike Y; Nakanishi T
Int J Hematol; 2019 Jan; 109(1):59-69. PubMed ID: 30232784
[TBL] [Abstract][Full Text] [Related]
17. A competitive enzyme-linked immunosorbent assay specific for murine hepcidin-1: correlation with hepatic mRNA expression in established and novel models of dysregulated iron homeostasis.
Gutschow P; Schmidt PJ; Han H; Ostland V; Bartnikas TB; Pettiglio MA; Herrera C; Butler JS; Nemeth E; Ganz T; Fleming MD; Westerman M
Haematologica; 2015 Feb; 100(2):167-77. PubMed ID: 25425686
[TBL] [Abstract][Full Text] [Related]
18. Pharmacologic inhibition of hepcidin expression reverses anemia of chronic inflammation in rats.
Theurl I; Schroll A; Sonnweber T; Nairz M; Theurl M; Willenbacher W; Eller K; Wolf D; Seifert M; Sun CC; Babitt JL; Hong CC; Menhall T; Gearing P; Lin HY; Weiss G
Blood; 2011 Nov; 118(18):4977-84. PubMed ID: 21730356
[TBL] [Abstract][Full Text] [Related]
19. Low anticoagulant heparin-iron complex targeting inhibition of hepcidin ameliorates anemia of chronic disease in rodents.
Li L; Wang X; Zhang H; Chen Q; Cui H
Eur J Pharmacol; 2021 Apr; 897():173958. PubMed ID: 33610598
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological suppression of hepcidin increases macrophage cholesterol efflux and reduces foam cell formation and atherosclerosis.
Saeed O; Otsuka F; Polavarapu R; Karmali V; Weiss D; Davis T; Rostad B; Pachura K; Adams L; Elliott J; Taylor WR; Narula J; Kolodgie F; Virmani R; Hong CC; Finn AV
Arterioscler Thromb Vasc Biol; 2012 Feb; 32(2):299-307. PubMed ID: 22095982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
